Chimeric Ad5.F35 vector evades anti-adenovirus serotype 5 neutralization opposing GUCY2C-targeted antitumor immunity.
Flickinger JC Jr, Singh J, Carlson R, Leong E, Baybutt TR, Barton J, Caparosa E, Pattison A, Rappaport JA, Roh J, Zhan T, Bashir B, Waldman SA, Snook AE.
Flickinger JC Jr, et al.
J Immunother Cancer. 2020 Aug;8(2):e001046. doi: 10.1136/jitc-2020-001046.
J Immunother Cancer. 2020.
PMID: 32819976
Free PMC article.